Bruker Q4 2019 Earnings Report
Key Takeaways
Bruker Corporation reported an 8.4% increase in revenue for Q4 2019, reaching $599.9 million. GAAP operating income was $117.7 million, with a margin of 19.6%. However, GAAP EPS decreased to $0.44, and non-GAAP EPS decreased to $0.53, driven by a higher effective tax rate.
Q4 2019 revenue increased by 8.4% to $599.9 million.
Organic revenue growth for Q4 2019 was 5.2%.
GAAP operating income for Q4 2019 was $117.7 million, representing a 19.6% margin.
GAAP EPS for Q4 2019 was $0.44, while non-GAAP EPS was $0.53.
Bruker
Bruker
Forward Guidance
Due to the challenging business conditions created by the global spread of COVID-19, Bruker is suspending its guidance for FY 2020. The Company expects to provide a business update on its first quarter 2020 earnings conference call in early May 2020.
Positive Outlook
- Bruker contributes to global healthcare.
- Bruker contributes to food supply.
- Bruker contributes to IT infrastructure.
- Bruker contributes to homeland security.
- Bruker continues to have a solid balance sheet and a strong liquidity position.
Challenges Ahead
- Bruker is suspending its guidance for FY 2020.
- Both revenue and earnings will be lower in the first quarter of 2020 than in the first quarter of 2019.
- The Company’s second quarter 2020 results are expected to be significantly negatively impacted by COVID-19 related disruptions to the Company’s operations
- The Company’s second quarter 2020 results are expected to be significantly negatively impacted by COVID-19 related disruptions to customer operations
- The Company’s second quarter 2020 results are expected to be significantly negatively impacted by COVID-19 related disruptions to global supply chains and logistics.